Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy.

Santiago-O'Farrill, Janice M; Kleinerman, Eugenie S; Hollomon, Mario G; Livingston, Andrew; Wang, Wei-Lien; Tsai, Jen-Wei; Gordon, Nancy B

Santiago-O'Farrill, Janice M; Kleinerman, Eugenie S; Hollomon, Mario G; Livingston, Andrew; Wang, Wei-Lien; Tsai, Jen-Wei; Gordon, Nancy B.

Afiliación

Santiago-O'Farrill JM; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kleinerman ES; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hollomon MG; Department of Biology, Texas Southern University, Houston, Texas, USA.
Livingston A; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wang WL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Tsai JW; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Gordon NB; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Oncotarget ; 9(2): 1602-1616, 2018 Jan 05.

Article en En | MEDLINE | ID: mdl-29416717

Palabras clave

Beclin; autophagy; gemcitabine; hydroxychloroquine; osteosarcoma

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google